newsfilter
← Latest News
PR Newswire·

Elevation Oncology to Participate at the JMP Securities Hematology and Oncology Summit

NEW YORK, Nov. 30, 2022 /PRNewswire/ -- Elevation Oncology, Inc. (NASDAQ:ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers,